Multicenter comparison of transcatheter aortic valve implantation with the self-expanding ACURATE neo2 versus Evolut PRO transcatheter heart valves.
Tobias RheudeCostanza PellegriniMartin LandtSabine BleizifferAlexander WolfMatthias RenkerJonas NeuserOliver DörrAbdelhakim AllaliTanja K RudolphJan Martin WambachJulian D WidderParminder SinghDominik BerlinerHector A Alvarez-CovarrubiasGert RichardtErion XhepaWon-Keun KimMichael JonerPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
Short-term outcomes after TAVI using latest-generation self-expanding THV were excellent, with overall low rates of adverse events. However, Neo2 was associated with lower pacemaker rates and reduced the prevalence of moderate-severe paravalvular leakage. Transprosthetic gradients after TAVI were higher with Neo2 compared with PRO.
Keyphrases
- transcatheter aortic valve implantation
- aortic valve
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve replacement
- anti inflammatory
- heart failure
- high intensity
- ejection fraction
- left ventricular
- atrial fibrillation
- early onset
- vena cava
- coronary artery disease
- cross sectional
- inferior vena cava